Key statistics
On Thursday, Gritstone bio Inc (2JQ:BER) closed at 0.5085, 24.51% above the 52 week low of 0.4084 set on Aug 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4958 |
---|---|
High | 0.509 |
Low | 0.474 |
Bid | 0.526 |
Offer | 0.5485 |
Previous close | 0.5145 |
Average volume | 2.00k |
---|---|
Shares outstanding | 118.11m |
Free float | 115.85m |
P/E (TTM) | -- |
Market cap | 64.77m USD |
EPS (TTM) | -1.35 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 19:08 BST.
More ▼
Announcements
- Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
- Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
- Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine
- Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million
More ▼